Image of a heart and medical equipment to show using new mitral valve repair procedure

NHS Digital launches National Record Locator Service

NHS Digital has taken an important step towards a more integrated health and care system with the launch of the new National Record Locator...
Investment in life science at Alderley Park

Major milestone in Unified Data Model project to promote life sciences collaboration

The Pistoia Alliance has announced a major milestone in Unified Data Model project to promote life sciences collaboration. The Pistoia Alliance, a global, not-for-profit alliance...
Sandoz biosimilar Ziextenzo approved with clipboard, notes and stethoscope

European Commission grants marketing authorisation for Sandoz biosimilar Ziextenzo ® (pegfilgrastim)

European Commission grants marketing authorisation for Sandoz biosimilar Ziextenzo ® (pegfilgrastim). Sandoz, a Novartis division, has announced that the European Commission (EC) has granted marketing authorisation...
GSK has reached an agreement to acquire oncology-focused biopharma company TESARO

Shionogi Ltd appoints Star for UK launch

Star is delighted to be partnering with specialist research-driven Japanese pharma company, Shionogi & Co., Ltd., as they launch a new product into the...
Pelmeg (pegfilgrastim) as a treatment for chemotherapy induced neutropenia.

EC approve Pelmeg▼® for chemotherapy induced neutropenia

European Commission (EC) has granted approval for the use of Pelmeg (pegfilgrastim) as a treatment for chemotherapy induced neutropenia.  The Mundipharma network of independent associated...
Strong opioid painkiller users have twice the risk of hip fracture compared to non-opioid users.

Strong painkillers increase hip fracture risk in Alzheimer’s patients

People with Alzheimer's disease using strong opioid painkillers have twice the risk of hip fracture compared to non-opioid users, according to a new study. The...
Investment in life science at Alderley Park

Autoimmune conditions costing UK billions each year

A report has revealed that rapidly rising rates of autoimmune conditions are costing the UK billions each year. The report, from Connect Immune Research, a...
A hand full of tablets showing NHS negotiates deals on adalimumab biosimilars

NHS negotiates deals on adalimumab biosimilars

The NHS negotiates deals on adalimumab biosimilars which could save £300 million. Simon Stevens has announced that the NHS is set to save a record £300...
Image of health money box to show PPRS replacement could save NHS save the NHS £930 million

PPRS replacement will offer faster access to new medicines and save money

The new PPRS replacement could see patients have faster access to new medicines, up to six months earlier, in a deal expected to save...
marketing authorisation for Buvidal granted

Camurus recieves EU marketing authorisation for Buvidal ®

Camurus has announced that the European Commission has granted marketing authorisation for Buvidal.  Buvidal® (CAM2038), the first and only long-acting injectable treatment available in both weekly...

Latest articles

Maxwellia makes two new appointments

Maxwellia expand their team with two new appointments

Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator. 
BMS & Boston Medical Center enter collaboration

BMS & Boston Medical Center announce research collaboration

BMS & Boston Medical Center enter research collaboration to investigate markers of immuno-oncology response and resistance Bristol-Myers Squibb Company...
Syringe with liquid

EC approves KEYTRUDA® as adjuvant therapy

MSD (Merck in the U.S. and Canada) has announced that the European Commission has approved its anti-PD-1 therapy, KEYTRUDA (pembrolizumab), for the adjuvant treatment...